Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06850350 · ClinicalTrials.gov registry record
Cognitive-Sensorimotor Function in Long-COVID
A clinical trial, sponsored by VA Office of Research and Development.
- Recruiting
- Registry status
- 136
- Enrollment target
NCT06850350: Recruiting study, sponsored by VA Office of Research and Development.
NCT06850350 is a clinical trial that is actively recruiting participants, run by VA Office of Research and Development. The registered enrollment target is 136 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06850350 is actively recruiting participants, sponsored by VA Office of Research and Development.
- RECRUITING
- Registry status
- 136 participants
- Enrollment target
Study Summary
Growing evidence indicates that many people who have chronic post-acute sequelae of SARS-CoV-2 infection (PASC) will experience ongoing neurological and musculoskeletal impairment that can affect gait and balance. Identifying the factors contributing to these impairments and how they influence functional mobility is the first step towards creating effective evaluation and treatment protocols. In this study the investigators will examine cognition, vision, proprioception, muscle strength, gait and balance in persons with and without PASC to understand how PASC may impact functional mobility through a cognitive-sensorimotor lens. Gait and balance will be studied in environments that stress cognitive and sensory abilities. Study outcomes will be critical for the development of evidence-based Veteran Health Administration diagnostic and standard-of-care protocols to address gait and balance dysfunction in Veterans with PASC for restoring their functional mobility and independence.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 136 participants |
| Start Date | 2026-04-01 |
| Est. Completion | 2030-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06850350
The ClinicalTrials.gov registry entry for NCT06850350 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 136 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT06850350 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06850350 about?
NCT06850350 is a clinical study titled "Cognitive-Sensorimotor Function in Long-COVID". Growing evidence indicates that many people who have chronic post-acute sequelae of SARS-CoV-2 infection (PASC) will experience ongoing neurological and musculoskeletal impairment that can affect gait and balance. Identifying the factors contributing to these impairments and how they influence funct...
What is the current status of trial NCT06850350?
This trial is currently recruiting. The enrollment target is 136 participants. The study started on 2026-04-01. Estimated completion is 2030-12-31.
Who is sponsoring clinical trial NCT06850350?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.